FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 353:1069-1070 September 8, 2005 Number 10 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Williams, H. C. PubMed Citation

To the Editor: In his thorough Clinical Practice article (June 2 issue),¹ Williams quotes two review articles^2,3 as his sources when he states, "Studies have failed to show clinically useful benefits from . . . viable lactobacilli (probiotics)." Since the publication in January 2005 of the article that specifically reviews probiotics,³ two double-blind, placebo-controlled, randomized trials have been published that contradict Willliams's conclusion. With supplementation with probiotics, Viljanen et al.⁴ found significant improvement on the Scoring Atopic Dermatitis (known as SCORAD) index only in "IgE-sensitized infants," but the improvement found by Weston and colleagues⁵ did not have such limitation.

Atopic . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.